( OTC-PINK:HADSY )

News from Hadasit Bio-Holdings Ltd. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 04, 2013, 08:30 ET Enlivex Therapeutics Publishes Positive Results from Phase I/II Clinical Trial for the Treatment of Bone Marrow Transplant Recipients

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property...


Jun 05, 2013, 09:22 ET Hadasit Bio-Holdings Ltd. to Present at the Third Annual Connecticut-Israel Technology Summit

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, based on intellectual property...


May 23, 2013, 15:22 ET Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, based on intellectual property developed...


Apr 09, 2013, 09:00 ET Hadasit Bio-Holdings CEO Letter to Shareholders

Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed...


Apr 04, 2013, 09:11 ET Hadasit Bio-Holdings Flagship Portfolio Company Enlivex Awarded Orphan Drug Status for ApoCell Treatment by the FDA

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property...


Feb 04, 2013, 08:30 ET KAHR Medical Granted U.S. Patent Approval for One of its Lead Products in Development, KAHR-101

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, based on intellectual property developed...


Jan 28, 2013, 09:00 ET Hadasit Bio-Holdings Ltd. Portfolio Companies - ProtAb Ltd. and KAHR Medical Ltd. to Receive NIS 10.7 Million (Over $2.8 Million USD) in Additional Government Grants

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY) and its portfolio companies ProtAb Ltd. ("ProtAb") and KAHR Medical Ltd. ("KAHR") announced...


Jan 22, 2013, 09:00 ET Hadasit Bio-Holdings' Portfolio Companies Receive Funding to Support Clinical Trial Preparations and Obtain Regulatory Approvals in U.S. and Europe

Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed...


Nov 12, 2012, 09:00 ET Hadasit Bio-Holdings Ltd. Portfolio Company Cell Cure Neurosciences Ltd. Receives Additional Financing From BioTime Inc.

 Hadasit Bio-Holdings Ltd. (OTC: HADSY, TASE: HDST) a publicly traded portfolio of biotech companies, all based on intellectual...


Oct 24, 2012, 09:00 ET Enlivex Therapeutics Announces Positive Results in Completion of Clinical Trial for the Treatment of Bone Marrow Transplant Recipients

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property...


Oct 16, 2012, 09:25 ET Hadasit Bio-Holdings to Participate in Hadassah Centennial Convention

 Hadasit Bio-Holdings Ltd. (OTC: HADSY, TASE: HDST) a publicly traded portfolio of biotech companies, all based on intellectual property...


Jul 12, 2012, 15:30 ET Hadasit Bio-Holdings Interviewed by Wall Street Reporter

 Hadasit Bio-Holdings Ltd. (OTC: HADSY, TASE: HDST) a publicly traded portfolio of biotech companies, all based on intellectual property...


Mar 29, 2012, 11:27 ET BioMarCare Receives Strategic Investment From Micromedic Ltd., a Subsidiary of BioLight Ltd.

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY) a publicly traded portfolio of biotech companies, all based on intellectual...


Mar 12, 2012, 16:00 ET Hadasit Bio-Holdings Ltd. Portfolio Companies - Thrombotech Ltd. and BioMarCare Technologies Ltd. to Receive Additional Government Grants

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY) and its portfolio companies Thrombotech Ltd. ("Thrombotech") and BioMarCare Technologies...


Jan 18, 2012, 10:30 ET Hadasit Bio-Holdings' Portfolio Company Thrombotech Raises $1.4M

Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY) a publicly traded portfolio of biotech companies, all based on intellectual property developed...


Oct 26, 2011, 08:30 ET Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders

The following is a letter to shareholders from Ophir Shahaf, CEO of Hadasit Bio-Holdings, Ltd. (OTCBB: HADSY), a publicly traded portfolio of...